Orbit

Orbit Neuro describes a mental-health and neurotechnology ambition: make mental health more understandable and actionable by developing a foundational model of the brain with non-invasive neurotechnology. Its website also frames the work as an interface to emotion, suggesting an interest in translating emotional experience into digital interaction. The structured category associated with the company is Web Development, which does not neatly align with its stated neurotechnology and mental-health focus. Its pre-seed stage and reported team size of 1–10 place it at an early development point relative to established digital mental-health and neurotechnology companies, but there is not enough evidence to assess comparative scale, clinical evidence, regulatory readiness, or market traction. Its position is therefore best understood as an early-stage, broadly described concept rather than a demonstrated competitive offering.

Orbit Neuro was founded in 2024 and is listed as an active, private company with a reported team size of 1–10. This establishes early external backing, but does not by itself indicate the company’s operating runway, hiring pace, or product progress. The company’s stated direction—using non-invasive neurotechnology toward a foundational model of the brain for mental-health applications—could require substantial technical and validation work. The website’s emotional-interface framing adds a possible design dimension, but provides no concrete launch or adoption milestone. Accordingly, the available evidence supports a trajectory from founding in 2024 to pre-seed financing in early 2026, while leaving key indicators of growth—technical milestones, customer activity, clinical validation, and follow-on funding—unclear.